Members |
targetComponentId |
Hyoscyamine sulfate 0.125mg/mL liquid |
Hyoscyamine sulfate 25 microgram/mL oral solution |
Hyperalphaglobulinemia |
Hyperalphaglobulinaemia |
Hyperbetaglobulinemia |
Hyperbetaglobulinemia |
Hyperchromia |
Hyperchromatism |
hyperkupremi |
Raised blood copper level (finding) |
Hypercupremia |
Raised blood copper level (finding) |
Hyperglobulinemia |
Hyperglobulinemia |
klinisk handläggningsplan för hyperglykemi |
Hyperglycemia clinical management plan |
egenvårdsplan vid hyperglykemi |
Hyperglycemia self management plan |
hyperhidros, prematura kaviteter och premolar aplasi |
Book syndrome (disorder) |
klinisk handläggningsplan för hyperlipidemi |
Hyperlipidaemia clinical management plan |
Hypermenorrhea |
Menorrhagia (finding) |
Hypermobility |
Musculoskeletal hypermobility |
Hyperpyrexia |
Hyperpyrexia (finding) |
klinisk handläggningsplan för hypertoni |
Hypertension clinical management plan (record artifact) |
Hypertensive ischemic ulcer |
Hypertensive ischemic ulcer |
hyperton natriumklorid |
Sodium chloride only product |
Hypertrichosis universalis |
Congenital hypertrichosis |
hypertrofisk kardiomyopati i samband med annan sjukdom |
Hypertrophic cardiomyopathy due to disorder |
hypertrofisk kardiomyopati sekundärt till Friedreichs ataxi |
Hypertrophic cardiomyopathy due to Friedreich ataxia |
hypertrofisk kardiomyopati sekundär till hypertyreos |
Hypertrophic cardiomyopathy due to hyperthyroidism |
hypertrofisk kardiomyopati sekundärt till neuromuskulär sjukdom |
Hypertrophic cardiomyopathy due to neuromuscular disorder |
hyperostos |
External hyperostosis |
hypertrofi av ben och brosk |
External hyperostosis |
broskhypertrofi |
Hypertrophy |
Hypoactive sexual desire disorder |
Lack or loss of sexual desire |
Hypoalphaglobulinemia |
Hypoalphaglobulinaemia |
Hypobetaglobulinemia |
Hypoalphaglobulinaemia |
Hypoglobulinemia |
Hypoglobulinaemia |
klinisk handläggningsplan för hypoglykemi |
Hypoglycemia clinical management plan (record artifact) |
egenvårdsplan vid hypoglykemi |
Hypoglycaemia self management plan |
Hypophysectomy by other specified approach |
Hypophysectomy |
Hyposensitivity |
Hyposensitivity |
syndrom med hypospadi, hypertelorism, kolobom och dövhet |
BSG syndrome |
klinisk handläggningsplan för hypotyreos |
Hypothyroidism clinical management plan |
hypotont konstgjort tårsubstitut, ögondroppar |
Medicinal product categorised by therapeutic role |
allergi mot ögondroppar med hypromellos |
Allergy to hypromellose |
iatrogen tatuering |
Iatrogenic tattoo |
ibandronatsyra 1 mg/ml, injektionsvätska, lösning, flaska 2 ml |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
ibandronatsyra 1 mg/ml, injektionsvätska, lösning, förfylld spruta 3 ml |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
ibandronatsyra 1 mg/ml, injektionsvätska, lösning, flaska 6 ml |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ibandronic acid 1mg/mL intravenous infusion conc |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ibandronic acid 1mg/mL intravenous infusion conc |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
ibuprofen 40 mg/ml, orala droppar |
Ibuprofen 40 mg/mL oral suspension |
ibuprofen 100 mg + pseudoefedrin 15 mg/5 ml, oral suspension |
Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Ichthyobodo nector |
Ichthyobodo necator (organism) |
peritonealdialysvätska med ikodextrin, 7,5 % |
Icodextrin only product |
idiopatisk interstitiell pneumoni |
Idiopathic pulmonary fibrosis (disorder) |
iodopatisk hypertrofisk subvalvulär aortastenos |
Hypertrophic obstructive cardiomyopathy |
Idiopathic hypertrophic subaortic stenosis |
Hypertrophic obstructive cardiomyopathy |
Idiopathic multifocal fibrosclerosis, NEC |
Multifocal fibrosclerosis |
Idiopathic proctocolitis |
Proctocolitis (disorder) |
Idiopathic purpura |
Immune thrombocytopenia |
Idiopathic respiratory distress syndrome |
Respiratory distress syndrome in the newborn |
Idiopathic retroperitoneal fibrosis |
Retroperitoneal fibrosis |
Idiopathic thrombocythemia |
Essential thrombocythemia |
idiopatiskt pojkflickbeteende |
Gender identity finding |
Idoxuridine 0.1% |
Idoxuridine 1 mg/mL eye solution |
Iliofemoral vascular bypass |
Iliofemoral shunt |
illegal abort med akut gul leveratrofi |
Induced termination of pregnancy complicated by acute necrosis of liver (disorder) |
Illegal abortion with specified complication, NEC |
Illegal abortion with complication (disorder) |
Illegitimate brother |
Sibling |
Illegitimate child |
Child |
Illegitimate daughter |
Daughter |
Illegitimate sibling |
Sibling |
Illegitimate sister |
Sister |
Illegitimate son |
Son |
iloprost 100 mikrogram/ml, infusionskoncentrat, ampull 1 ml |
Iloprost (as iloprost trometamol) 100 microgram/mL solution for injection |
iloprost 10 mikrogram/ml, lösning för nebulisator, ampull 1 ml |
Product containing precisely iloprost 10 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
iloprost 10 mikrogram/ml, lösning för nebulisator, ampull 2 ml |
Product containing precisely iloprost 10 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
Imam |
Imam |
Imatinib 100mg capsule |
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
Imatinib mesylate 100mg capsule |
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
Imatinib mesylate 400mg capsule |
Imatinib (as imatinib mesilate) 400 mg oral capsule |
Imidapril hydrochloride |
Product containing imidapril (medicinal product) |
imidazolättiksyra |
Imidazole |
Imiglucerase 200unt injection |
Imiglucerase 200 unit powder for solution for injection vial |
Imiglucerase 400u powder for infusion solution vial |
Imiglucerase 400 unit powder for solution for injection vial |
Imipenem 500mg/cilastatin 500mg powder for infusion solution transfer vial |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
imipenem 500 mg/cilastatin 500 mg, pulver till injektionsvätska, lösning, flaska |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
imipenem 750 mg + cilastatin 750 mg, pulver till injektionsvätska, flaska |
Product containing only cilastatin and imipenem in parenteral dose form (medicinal product form) |
Immature lungs |
Primary atelectasis, in perinatal period |
Immune system observation |
Immune system finding |
immun trombocytopen purpura |
Autoimmune thrombocytopenia (disorder) |
idiopatisk trombocytopen purpura |
Immune thrombocytopenia |
immunbrist med multikarboxylasbrist |
Multiple carboxylase deficiency |
Immunologic paralysis |
Immunologic tolerance |
Immunologic unresponsiveness |
Immunologic tolerance |
Immunoproliferative disease - morphology |
Immunoproliferative disease (morphologic abnormality) |
immunproliferativ sjukdom |
Immunoproliferative disease (morphologic abnormality) |
Impaired glucose tolerance associated with unlisted conditions |
Impaired glucose tolerance |
opersonlig miljö |
Impersonal environment (finding) |
ogenomtränglig uretra |
Congenital stricture of urethra |
Implant |
Implant |
Implant-related action |
Insertion - action (qualifier value) |
interoperativ testkabel till implanterbart system för elektrisk stimulering |
Implantable electrical stimulation system intraoperative test lead |
Implantation as cylinder |
Insertion - action (qualifier value) |
Implantation of inert material in orbit |
Implantation procedure (procedure) |
Implantation of inert material in orbit, reinsertion |
Implantation procedure (procedure) |
Implantation of inert material in scleral shell, reinsertion |
Implantation procedure (procedure) |
Implantation of peripheral nerve |
Transplantation of peripheral nerve |